- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
hHBA1/hHBA2/hHBQ1 Humanized Mouse Model
| Strain Name | hHBA-A1/hHBQ1b/hHBA-A2 Humanized Mouse Model |
|---|---|
| Editing Type | Humanize/Knockin |
| Gene Name | Mouse: Hba-a1 / Hba-a2 / Hbq1b |
| Gene Synonyms | Hba-a1: Hba; Hba1; Hbat1 |
| Strain Background | C57BL/6N |
| NCBI No. | Mouse: Gene ID: 15122 / MGI:96015|Gene ID: 110257 / MGI:96016|Gene ID: 544763 / MGI:3613460 |

1. Hemoglobin assembly and erythroid biology Investigate how human alpha-globin (HBA1, HBA2) supports erythroid development, hemoglobin tetramer assembly, and oxygen binding, and how the alpha-chain dosage these two loci supply sets erythrocyte deformability and oxygen affinity. Theta-globin (HBQ1) is included as an early-erythroid member of the human alpha cluster for developmental studies, not as a tetramer subunit.
2. Alpha-thalassemia and hemoglobinopathy mechanisms Model haploinsufficiency, deletion, or functional impairment across the four alpha loci to reproduce the clinical gradient of alpha-thalassemia—silent carrier, trait, HbH disease, and phenotypes relevant to Hb Bart hydrops fetalis. Study free alpha-chain precipitation, ineffective erythropoiesis, hemolysis, and extramedullary hematopoiesis driven by alpha/non-alpha chain imbalance.
3. Globin switching and cluster regulation Use the human cluster members present in this strain—early-expressed HBQ1 and adult-type HBA1/HBA2—to study developmentally staged expression, globin switching, and the function of cluster regulatory elements. Evaluate the effect of alpha-specific chaperones and epigenetic modifiers, including AHSP, on the human alpha-globin expression profile.
4. Gene therapy and therapeutic evaluation Evaluate in vivo expression efficiency, phenotypic rescue, and safety of human alpha-globin-directed gene addition, base editing, gene correction, and hematopoietic stem cell gene therapy. Serve as a human-globin background for globin stabilization and adjunctive antioxidant strategies. HbF reactivation is a beta-cluster strategy and becomes relevant on this background once combined with a humanized beta-globin strain.
5. Erythrocyte physiology and stress Investigate changes in human globin expression and compensatory mechanisms under acquired erythroid disorders such as oxidative stress, hypoxia, blood loss, and hemolysis. Assess how distinct globin subunit compositions balance physiological oxygen transport against pathological erythrocyte damage.
The hHBA1/hHBA2/hHBQ1 Humanized Mouse Model is generated by replacing sequences at the mouse alpha-globin locus with the human HBA1, HBA2, and HBQ1 genes, so that mice express human alpha-globin subunits in erythroid cells. HBA1 and HBA2 encode the alpha-globin chains that, together with beta chains, form adult hemoglobin HbA (α₂β₂); the two coding sequences are identical and differ only in their untranslated regions and introns, so their combined product is a single protein supplied from two loci. That two-locus arrangement is the point of the model: the human alpha cluster carries four alpha genes in total, and reducing that number one copy at a time reproduces the graded clinical spectrum of alpha-thalassemia rather than a single all-or-nothing knockout. HBQ1 (theta-globin) sits at the 3′ end of the same cluster and is transcribed in fetal erythroid tissue but not in adult erythroid cells, making it a marker of the cluster’s developmental regulation. Together these three human sequences place alpha-globin expression, chain balance, and cluster-level control under human sequence in a living animal, providing a platform for studying alpha-thalassemia mechanisms, globin switching, and preclinical evaluation of alpha-globin-directed gene therapies.
1. The four-locus dosage gradient is preserved. Human alpha-globin comes from four gene copies. Replacing the mouse locus with human sequence lets you remove copies one at a time and read out silent carrier, trait, and HbH-length phenotypes in sequence, instead of a single lethal knockout.
2. Identical coding, distinct regulation. HBA1 and HBA2 encode the same protein but differ in their untranslated regions and introns, so the strain separates protein-level questions from expression-level ones.
3. Cluster-level, not transgene-level. All three human sequences sit in the endogenous alpha cluster rather than at a random integration site, keeping developmental stage specificity and long-range enhancer control in play.
4. An early-erythroid marker built in. HBQ1 is transcribed in fetal erythroid tissue and silent in adult erythroid cells, giving a direct readout of cluster developmental regulation in the same animal.
5. Defined inbred background. Established on C57BL/6N for uniform background and reproducible phenotypes.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
